PATENT CLAIM ANALYSIS

Application Number: 16081578
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "007200"]

Abstract:
In one aspect, methods of treating hyperinsulinemic hypoglycemia comprising administration of an effective amount of a derivative of an exendin-4 peptide are provided. In some embodiments, the method comprises subcutaneously administering to a patient having hyperinsulinemic hypoglycemia a therapeutically effective amount of exendin(5-39).

Claim (Index 15):
The method of  claim 1 , wherein the exendin-4 derivative is exendin(5-39) and wherein the exendin(5-39) is subcutaneously administered at a dose of 0.5 mg to 30 mg BID.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 96.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15576646', '15576647', '12717794', '13680753', '15230340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7486205034011916
- 35 USC 102 Novelty (BERT): 0.5281981460007796
- Combined Prediction Score: 0.7265782676611504
- Mean Citation Score: 250.69600800000003
- Max Citation Score: 332.82516
- Similarity Product: 224.6495477455473

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test